Silymarin improves CCl4-induced liver fibrosis through enhancing of Egr1 accumulation in nucleus, decreasing serum HMGB1 levels, and inhibiting hepatic EndoMT in mice(Wei et al. 2022). The gene discussed is HMGB1; the disease is Hepatic fibrosis.